Skip to main content
欧康医药 logo

欧康医药 — Investor Relations & Filings

Ticker · 920230 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 373 across all filing types
Latest filing 2025-08-31 Governance Information
Country CN China
Listing Beijing Stock Exchange 920230

About 欧康医药

https://www.okaypharm.com/

Oukang Pharmaceutical specializes in the research, development, and large-scale production of natural plant extracts, with a primary focus on citrus-derived flavonoids. The company’s core product portfolio includes high-purity ingredients such as Hesperidin, Diosmin, Methyl Hesperidin, and Neohesperidin Dihydrochalcone (NHDC). These products serve as essential raw materials for the global pharmaceutical, nutraceutical, food and beverage, and cosmetic sectors. Utilizing advanced extraction and purification technologies, the company maintains rigorous quality control standards to ensure compliance with international regulatory requirements. Its operations emphasize the industrialization of plant-based chemical derivatives to support diverse health and wellness applications.

Recent filings

Filing Released Lang Actions
独立董事专门会议工作制度
Governance Information Classification · 95% confidence The document is titled as a work system for the Independent Directors' Special Meeting of Chengdu Oukang Pharmaceutical Co., Ltd. It details the procedures, responsibilities, and governance related to independent directors' meetings, including voting, meeting notices, and the scope of matters to be discussed. There is no financial data, earnings information, or report publication mentioned. The content focuses on governance practices and internal rules for board operations, specifically for independent directors. This aligns with the definition of Governance Information (CGR), which covers the company's internal rules, board structure, and governance practices. The document length is 3297 characters, which is sufficient for a detailed governance document rather than a brief announcement or certification. Therefore, the appropriate classification is CGR with high confidence.
2025-08-31 Chinese
第四届监事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the ninth meeting of the fourth Supervisory Board of Chengdu Oukang Pharmaceutical Co., Ltd. It details the meeting's attendance, agenda items, and voting results. The content focuses on governance matters such as the proposal to abolish the Supervisory Board and amend the company's articles of association, the repeal of Supervisory Board rules, and the proposal to reappoint the auditing firm. It does not contain financial statements or detailed financial data, nor is it a transcript or presentation. It is an official announcement of board/management decisions related to governance structure changes. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not merely announcing a report publication but actual meeting resolutions. Confidence is high due to clear governance content and meeting resolution format.
2025-08-31 Chinese
承诺管理制度
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of the company's internal management system related to commitment management, including the rights and obligations of the parties involved, procedures for approval, and disclosure requirements. It is a formal announcement from the board of directors about the adoption and content of a management system, not a financial report or earnings release. The document length is 2575 characters, which is relatively short and does not contain financial statements or data. It is not a report publication announcement because it contains the full text of the management system, not just a notice of publication. It is not related to board changes, voting results, or legal proceedings. The content fits best under a regulatory announcement category related to internal management and compliance disclosures. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2025-08-31 Chinese
董事会审计委员会工作细则
Governance Information Classification · 100% confidence The document is titled "成都欧康医药股份有限公司董事会审计委员会工作细则" which translates to "Chengdu Oukang Pharmaceutical Co., Ltd. Board Audit Committee Working Rules." It details the structure, responsibilities, and procedures of the audit committee under the board of directors. The content includes governance rules, committee member composition, duties related to auditing and internal controls, meeting procedures, and reporting obligations. There is no financial data, no financial statements, no earnings information, no voting results, no capital changes, or any other financial disclosures. It is a governance document outlining internal rules and practices related to the audit committee. Therefore, it fits best under Governance Information (CGR). The document length (7201 characters) and detailed procedural content support this classification.
2025-08-31 Chinese
年报信息披露重大差错责任追究制度
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '年报信息披露重大差错责任追究制度' (Annual Report Information Disclosure Major Error Responsibility Pursuit System) issued by the board of Chengdu Oukang Pharmaceutical Co., Ltd. It outlines procedures, responsibilities, and penalties related to major errors in annual report disclosures. It does not contain actual financial data or financial statements, nor is it an announcement of a report publication. It is a governance-related document focusing on internal control and accountability regarding annual report disclosures. Therefore, it fits best under Governance Information (CGR). The document length is 4671 characters, which is substantial and contains detailed policy content rather than a brief announcement or certification.
2025-08-31 Chinese
总经理工作细则
Board/Management Information Classification · 95% confidence The document is titled as the 'General Manager Work Rules' of Chengdu Oukang Pharmaceutical Co., Ltd., detailing the internal management system for the company's general manager and senior management. It includes sections on appointment qualifications, duties, meeting procedures, reporting obligations, and other governance-related rules. The document is a formal announcement of internal management policies approved by the board of directors. It does not contain financial statements, audit results, earnings data, or shareholder voting results. It is not a report of financial performance or an announcement of a report publication. The content focuses on governance and management structure and rules, which fits the category of Board/Management Information (MANG). The document length is 4725 characters, which is sufficient for a detailed management information announcement rather than a brief notice. Therefore, the appropriate classification is MANG with high confidence.
2025-08-31 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.